Clinical trials
Observational Thoracic Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 6 |
| Unknown status | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Al-Nahrain University | 3 |
| Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 2 |
| Ain Shams University | 1 |
| Anna Rockich | 1 |
| Antalya Training and Research Hospital | 1 |
| Azienda Usl di Bologna | 1 |
| Caner İşevi, MD | 1 |
| Chang Gung Memorial Hospital | 1 |
| Corporacion Parc Tauli | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thoracic Injuries | 31 |
| Wounds and Injuries | 8 |
| Rib Fractures | 5 |
| Multiple Trauma | 4 |
| Flail Chest | 3 |
| Abdominal Injuries | 2 |
| Emergencies | 2 |
| Pneumothorax | 2 |
| Respiratory Insufficiency | 2 |
| Wounds, Nonpenetrating | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.